Metraipolis › archive › dc_5ce78e2e7e5b

Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155373
DOI
10.3390/ijms262010082
License (as archived)
solo-consultazione
Archived
2026-11-09T06:58:50.784Z
SHA-256 of the archived text
38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4
Stable URL of this page
https://metraipolis.com/documento/dc_5ce78e2e7e5b

How to cite

Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373 — Europe PMC (en), https://europepmc.org/article/MED/41155373 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ce78e2e7e5b (Metraipolis archive dc_5ce78e2e7e5b, sha256 38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4)
BibTeX
@misc{dc5ce78e2e7e5b,
  title = {Engineering Bispecific Peptides for Precision Immunotherapy and Beyond — Europe PMC PMID:41155373},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155373},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ce78e2e7e5b; sha256 38a408e8d7a2ea344491b0a8106a7d875bdbf335abfb6766f4f0642115ad56f4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155373. Agents can read the archived copy with the MCP tool read_document.